BFA
SLS icon

BlackRock Fund Advisors’s SELLAS Life Sciences SLS Stock Holding History

BlackRock Fund Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$683K Buy
+235
New +$1.37M ﹤0.01% 3245

Other funds holding SLS

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock Fund Advisors's SLS Position: Q4 2016 in Review

BlackRock Fund Advisors opened a new position in SELLAS Life Sciences (SLS) in Q4 2016: 235 shares worth $683K. The stake represents ﹤0.01% of the portfolio and ranks #3245 among its holdings.

44 funds tracked by Wall St. Rank hold SLS as of Q4 2016.

  • BlackRock Fund Advisors held 235 shares of SELLAS Life Sciences worth $683K as of Q4 2016.
  • SELLAS Life Sciences was a new BlackRock Fund Advisors position in Q4 2016.
  • SELLAS Life Sciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3245 holding.
  • 44 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.